Stem Sellouts
By Jesse Reynolds,
TomPaine.com
| 07. 19. 2005
Recent developments—both technical and political —have once again brought stem cell research to the front pages of newspapers across the country. Sens. Tom Harkin, D-Iowa, and Arlen Specter, R-Pa., are the sponsors of a bill in the Senate that would largely undo President Bush’s restrictive federal funding policies. It’s already passed the House, and is scheduled for a Senate vote this month. But now conservatives are working to dilute support for it by introducing several competing bills that would fund stem cell research that does not destroy human embryos.
Progressives are inclined to react to these reports by strengthening their support of stem cell research as an effective wedge issue to split Republicans. But before we move ahead with simplistic calls for more funding and fewer restrictions, we should pay heed to troubles with California’s new stem cell research agency— and to the larger implications of biotech boosterism.
California’s Calamity
Last fall, Californians approved Proposition 71, which established the Institute for Regenerative Medicine to distribute $3 billion in stem cell research grants. Voters were swayed, with the help of a...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...